Australia markets closed

Krystal Biotech, Inc. (KRYS)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
163.97-5.67 (-3.34%)
At close: 04:00PM EDT
163.01 -0.96 (-0.59%)
After hours: 04:18PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
50,699
50,699
0
0
0
Cost of revenue
3,094
3,094
0
0
-
Gross profit
47,605
47,605
0
0
-
Operating expenses
Research development
46,431
46,431
42,461
27,884
17,936
Selling general and administrative
98,401
98,401
77,735
40,391
15,063
Total operating expenses
144,832
144,832
120,196
68,275
32,999
Operating income or loss
-97,227
-97,227
-120,196
-68,275
-32,999
Interest expense
0
0
0
1,492
0
Total other income/expenses net
87,500
87,500
-25,000
-
-
Income before tax
12,897
12,897
-139,975
-69,570
-32,167
Income tax expense
1,965
1,965
0
0
-
Income from continuing operations
10,932
10,932
-139,975
-69,570
-32,167
Net income
10,932
10,932
-139,975
-69,570
-32,167
Net income available to common shareholders
10,932
10,932
-139,975
-69,570
-32,167
Basic EPS
-1.17
-
-5.49
-3.13
-1.71
Diluted EPS
-1.17
-
-5.49
-3.13
-1.71
Basic average shares
26,530
-
25,492
22,197
18,787
Diluted average shares
26,959
-
25,492
22,197
18,787